Read highly accessed rare diseases research.

Submit a manuscript

Editorial Board

Author Instructions

Article Alerts

Dear Prof CERASALE MORTEO,

I would like to share with you some articles published in the open access journal,Orphanet Journal of Rare Diseases, and invite you to submit your next manuscript to us.

Selection of highly accessed articles

	Review  The quality of economic evaluations of ultra-orphan drugs in Europe - a systematic review Y Schuller, C Hollak, M Biegstraaten 10:92 (30 July 2015)
	Research  Quality of life in patients with locked-in syndrome: Evolution over a 6-year period M Rousseau et al. 10:88 (19 July 2015)
	Research  Safety and efficacy of exercise training in adults with Pompe disease: evalution of endurance, muscle strength and core stability before and after a 12 week training program L van den Berg et al. 10:87 (19 July 2015)

About Orphanet Journal of Rare Disease

Orphanet Journal of Rare Diseases is an open access, online journal that encompasses all aspects of rare diseases and orphan drugs. The journal publishes high-quality reviews on specific rare diseases. In addition, the journal may consider articles on clinical trial outcome reports, either positive or negative, and articles on public health issues in the field of rare diseases and orphan drugs.

Reasons to publish with Orphanet Journal of Rare Diseases

	Top-ranking journal dedicated to rare diseases according to the Journal Citation Reports
	High-quality peer-review service, handled by almost 30 Section Editors across 19 subject-specific Sections
	Rapid publication following acceptance
	No space constraints nor limits on the number of color figures, movies or additional files

Keep up to date – get the latest articles delivered straight to your inbox.

Best wishes,

Ségolène Aymé
Editor-in-Chief, Orphanet Journal of Rare Diseases

For further information or enquiries please contact Customer Services at: info@biomedcentral.com.

BioMed Central Ltd, 236 Gray's Inn Road, London, WC1X 8HB, United Kingdom. Part of Springer Science+Business Media. Privacy Policy.